Vigilare Wealth Management Arrowhead Pharmaceuticals, Inc. Transaction History

Vigilare Wealth Management

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 11, 2022	SELL	$27.79 - $50.61 $158,125 - $287,970	-5,690 Closed	0 $0
Q1 2022 Apr 06, 2022	SELL	$39.62 - $69.97 $79,834 - $140,989	-2,015 Reduced 26.15%	5,690 $262,000
Q4 2021 Jan 07, 2022	SELL	$58.09 - $82.51 $34,273 - $48,680	-590 Reduced 7.11%	7,705 $511,000
Q3 2021 Oct 19, 2021	BUY	$58.38 - $84.96 $194,113 - $282,492	3,325 Added 66.9%	8,295 $518,000
Q2 2021 Jul 16, 2021	BUY	$62.15 - $90.32 $111,248 - $161,672	1,790 Added 56.29%	4,970 $412,000
Q1 2021 Apr 29, 2021	BUY	$61.35 - $90.47 $195,093 - $287,694	3,180 New	3,180 $211,000

295

91.1M

155K

426K

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $1.96B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

Get notified when there are updates to the investment portfolio of Vigilare Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Vigilare Wealth Management with notifications on news.